UnitedHealth stock surged 7.89% after reporting quarterly revenue of $111.72 billion, surpassing the expected $109.57 billion, and earnings per share of $7.23 versus $6.57 forecast. The strong earnings follow a recent 20% rise and a government decision to increase Medicare Advantage payments, boosting investor confidence. Wall Street analysts now rate UNH as a 'Strong Buy' with an average 12-month price target of $368.70, though some caution remains due to the stock's rapid gains. The outlook suggests continued growth for UnitedHealth and the healthcare insurance sector in 2026.
The SCHD ETF has returned just under 2% in the past month, outperforming the S&P 500 ETF (SPY) by nearly 1%. Year-to-date, about 30 SCHD holdings have more than doubled the returns of SPY, which has returned 9.8%. Additionally, 31 SCHD holdings are t...
Elevance Health and UnitedHealth Group, two of the largest U.S. health insurers, are set to report their second-quarter earnings this week. Investors and analysts are watching closely to see if these companies have maintained control over rising medi...
